Teladoc Health, Inc.
$7.09
-6.0%Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.
At a Glance
Live SnapshotIntrinsic Alpha Methodology
Thesis Lenses
Signal
Medium confidenceValuation multiple is compressed (P/E -6.2).
Valuation inputs: P/E -6.2, earnings yield N/A, momentum -6.0%.
If multiples stay elevated while momentum fades, downside repricing risk rises.
Driver
High confidenceReturn profile is soft (ROE -14.5%, ROIC -8.3%).
Profitability stack: net margin -7.9%, ROE -14.5%, ROIC -8.3%.
Quality deterioration often appears in margins before it shows up in headline EPS.
Risk
High confidenceRisk profile is balanced but has notable pressure points to monitor.
Risk factors: liabilities/assets +55.3%, momentum -6.0%, net margin -7.9%.
Higher leverage with weak momentum and thin margins can amplify drawdown severity.
Teladoc Health, Inc. Market vs Earnings Trajectory
Loading price and EPS data...
Teladoc Health, Inc. Fair Value Envelope
Teladoc Health, Inc. Profit Bridge
Profitability Analysis
Gross Margin
Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.
Operating Margin
Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.
Net Profit Margin
Net losses indicate the company is burning cash. Sustainability depends on path to profitability.
Profitability Insight
Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.
Teladoc Health, Inc. Cash Conversion Engine
Cash Flow Quality Analysis
FCF Conversion Rate
Negative free cash flow despite positive earnings raises concerns about cash generation ability or heavy capital requirements.
CapEx Intensity
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
FCF Growth Trend
Flat FCF growth. Stable but not expanding—monitor for signs of business maturity or temporary headwinds.
Working Capital Impact
Working capital inflow boosted cash flow. Efficient management of receivables, inventory, and payables contributing positively.
Teladoc Health, Inc. Funding & Solvency Profile
Financial Health Analysis
Current Ratio
Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.
Debt-to-Equity Ratio
Elevated leverage. Debt exceeds equity, which amplifies both gains and risks. Monitor debt servicing ability.
Working Capital
Strong working capital position provides significant operational flexibility and financial cushion.
Asset Composition
Balanced asset mix between current and non-current assets, typical of many stable businesses.
Teladoc Health, Inc. Street Expectations Map
Wall Street analysts project that TDOC stock may experience modest gains over the coming 12 months. The consensus 1-year price target stands at 7.58, with estimates ranging from a low of 6.00 to a high of 11.00.
The consensus 1-year price target stands at 7.58, with estimates ranging from a low of 6.00 to a high of 11.00.
Analyst Consensus Analysis
Upside Potential
Moderate upside. Analysts expect positive returns but with limited margin of safety. Consider entry timing.
Analyst Agreement
High uncertainty. Very wide target spread indicates significant disagreement among analysts—major valuation uncertainty or transformation underway.
Risk-Reward Profile
Favorable risk-reward. Potential upside significantly exceeds downside risk, offering asymmetric return profile attractive for risk-tolerant investors.
Analyst Conviction
High uncertainty: Wide dispersion indicates analysts struggle to agree on valuation—proceed with caution and independent analysis.
Market Sentiment Insight
Monitor and evaluate: Current analyst consensus suggests limited conviction or near-term catalysts. Stay informed on company developments and reassess positioning as new information emerges.
Teladoc Health, Inc. Insider Positioning
During the last 12 months, insiders have purchased $69K and sold $1.39M worth of TDOC shares, resulting in $1.32M of net selling activity.
3 Months
0
0.00
28.4K
155.69K
-156K
-$156K
3-6 Months
0
0.00
123.1K
674.60K
-675K
-$675K
6-9 Months
10.0K
69.40K
40.5K
306.07K
-237K
-$237K
9-12 Months
0
0.00
33.9K
257.48K
-257K
-$257K
Top Buyers
Paulus Kenneth H
Director
$69K
Top Sellers
Divita Charles Iii
Director, Officer: Chief Executive Officer
$667K
Vandervoort Adam C
Officer: Chief Legal Officer, Secretary
$226K
Bliss Kelly
Officer: President, U.S. Group Health
$206K
Rodrigues Fernando M.
Officer: President Of Betterhelp
$98K
Murthy Mala
Officer: Chief Financial Officer
$97K
Insider Activity Analysis
Net Insider Sentiment
Strong bearish signal with $1.32M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Buy/Sell Ratio
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
Recent Trend (3 Months)
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
Insider Participation
5 insider sellers vs. 1 buyers. Widespread selling across multiple insiders may signal concerns.
Insider Activity Insight
Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.
No Dividend Yield Data
TDOC has not reported any dividend yield values in the available annual periods.
tdoc Dividend History
Learning Layer
Related Guides
Build conviction on TDOC by pairing this stock hub with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.